Slide 1: Dexcom earnings Q2 2023
bpexcom Dexcom earnings Q2 2023
Slide 2: Safe Harbor Statement
Safe Harbor Statement pexcom This presentation contains "forward" looking statements that are based on our management's beliefs and assumptions and on information currently available to management. We intend for such forward-looking statements to be covered by the safe harbor provisions for forward-
Slide 3: Second quarter 2023 Key Financial and Strategic Highlights
Second quarter 2023 © Key Financial Highlights iil Strong growth with $871 million in revenue 26% organic revenue growth! (21% US; 40% OUS?) Generated over 450 basis points of operating expense leverage Highest year-over-year absolute dollar compared to Q2'22 growth in company history Delivered 100%
Slide 4: Second quarter performance
Second quarter performance Total Revenue & Organic Growth Rate! Non-GAAP Gross Profit and % Margin* ($m™) ($MM) $900 $696 $770 i $744 = $200 | $450 $494 aa $470 sss $675 $400 $450 $300 200 $225 a +20% +20% +19% +26% TM 64.6% 64.2% 66.7% 63.4% 63.5% $0 $0 Q2'22 Q3'22 Q4'22 Q123 Q2'23 Q2'22 Q3'22 Q4'2
Slide 5: 2023 Guidance as of July 27, 2023
2023 Guidance as of July 27, 2023 2023 Annual Revenue and Profitability Guidance Non-GAAP Non-GAAP Adjusted Revenue Gross Profit Margin* Operating Margin* EBITDA Margin* . USD Previous 3.400-3.515 62-63% ~16.5% ~26% billion USD Updated 3.500-3.550 ~63% ~17% ~26.5% billion “Adjusted EBITDA defined as
Slide 6: Appendix: Revenue Data and GAAP Reconciliations
bexcom Appendix Revenue Data and GAAP Reconciliations
Slide 7: GAAP to non-GAAP reconciliations
Three Months Ended June 30, Three Months Ended June 30, (In millions) 2023 2022 (In millions, except per share data) 2023 2022 GAAP gross profit $ 546.4 $ 449.5 GAAP net income $ 115.9 $ 50.9 Amortization of intangible assets (1) 7.1 — Amortization of intangible assets (1) 8.8 1.9 Non-GAAP gross pro
Slide 8: Revenue Metrics By Component
Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 YTD' 21 YTD' 22 YTD' 23 Revenue Metrics By Component Sensor & Other Revenue (millions) (1) (2) $ 424.3 $ 494.5 $ 547.9 $ 598.6 $ 543.2 $ 597.7 $ 666.6 $ 714.8 $ 651.9 $ 778.0 $ 918.8 $1,140.9 $1,429.9 Year over year growth 31% 36% 35% 29% 2
Slide 9: Revenue Metrics By Geography
Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 YTD' 21 YTD' 22 YTD' 23 Revenue Metrics By Geography US Revenue (millions) $ 381.2 $ 461.5 $ 489.6 $ 517.1 $ 451.2 $ 511.0 $ 573.4 $ 606.4 $ 526.0 $ 616.6 $ 842.7 $ 962.2 $1,142.6 Year over year growth 30% 26% 23% 15% 18% 11% 17% 17% 17% 21
Slide 10: Organic Revenue
Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 YTD' 21 YTD' 22 YTD' 23 1 Organic Revenue INT'L Revenue - Reported $ 123.8 $ 133.6 $ 160.6 $ 181.1 $ 177.6 $ 185.2 $ 196.2 $ 208.8 $ 215.5 $ 254.7 $ 257.4 $ 362.8 $ 470.2 Impact of Acquired Revenue and Foreign Exchange (5.4) (7.3) (13.6) (1
Slide 11: Definitions
DexCom, Inc. Definitions: Amortization of intangible assets — We are required by GAAP to record the fair values of the intangible assets of the entity on our balance sheet and amortize them over their useful ives. We exclude these non-cash amortization charges related to acquired intangible assets f